Qingdao Vland Biotech INC banner

Qingdao Vland Biotech INC
SSE:603739

Watchlist Manager
Qingdao Vland Biotech INC Logo
Qingdao Vland Biotech INC
SSE:603739
Watchlist
Price: 14.74 CNY -8.1% Market Closed
Market Cap: ¥3.7B

Relative Value

The Relative Value of one Qingdao Vland Biotech INC stock under the Base Case scenario is 21.07 CNY. Compared to the current market price of 14.74 CNY, Qingdao Vland Biotech INC is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
21.07 CNY
Undervaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Qingdao Vland Biotech INC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Qingdao Vland Biotech INC
SSE:603739
3.7B CNY 2.7 44.6 28.2 28.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
362.5B USD 5.9 86.5 14.4 20
US
Amgen Inc
NASDAQ:AMGN
187.5B USD 5.1 24.5 14.2 14.2
US
Gilead Sciences Inc
NASDAQ:GILD
170.3B USD 5.8 20.2 12.6 15.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.3B USD 9.6 29.3 22 23
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.5B USD 5.5 17.5 12.9 14.7
AU
CSL Ltd
ASX:CSL
66.8B AUD 3.1 34.3 11.3 14.3
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.8 -66.6 -60.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.3B USD 11.1 130.8 73.2 81.3
P/E Multiple
Earnings Growth PEG
CN
Qingdao Vland Biotech INC
SSE:603739
Average P/E: 48.5
44.6
25%
1.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
86.5
97%
0.9
US
Amgen Inc
NASDAQ:AMGN
24.5
20%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
20.2
16%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.3
17%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
13%
1.3
AU
CSL Ltd
ASX:CSL
34.3
10%
3.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
130.8
84%
1.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Qingdao Vland Biotech INC
SSE:603739
Average EV/EBITDA: 23.6
28.2
49%
0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
14.4
12%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
10%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
9%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.9
18%
0.7
AU
CSL Ltd
ASX:CSL
11.3
7%
1.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
73.2
67%
1.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Qingdao Vland Biotech INC
SSE:603739
Average EV/EBIT: 26.4
28.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
20
23%
0.9
US
Amgen Inc
NASDAQ:AMGN
14.2
3%
4.7
US
Gilead Sciences Inc
NASDAQ:GILD
15.6
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.7
23%
0.6
AU
CSL Ltd
ASX:CSL
14.3
10%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
81.3
69%
1.2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett